# OnCo record nct00438984 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct00438984/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct00438984", "NCT00438984" ;
  schema:name "CD8+ antigen-specific T-cell clones after cyclophosphamide, with aldesleukin, in stage IV melanoma (Fred Hutchinson phase 1, NCI-2010-01280)"@en ;
  schema:description "A Seattle trial in 11 people with advanced melanoma that gave cyclophosphamide before their own melanoma-targeting T cells, followed by the immune signal IL-2. It ran from 2006 to 2012."@en ;
  schema:url <https://onco.cc/trials/nct00438984/> ;
  schema:dateModified "2026-11-05"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00438984> ;
  onco:status "completed" ;
  onco:phase "1" ;
  schema:startDate "2006-12" ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:drugs <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/aldesleukin/> ;
  onco:institutions <https://onco.cc/institutions/fred-hutch/>, <https://onco.cc/institutions/nci/> ;
  onco:terms <https://onco.cc/terms/endogenous-t-cell-therapy/> ;
  onco:people <https://onco.cc/people/cassian-yee/> .